Skip to content

Study on the efficacy and safety of Life Enhancer compound probiotics in the treatment of patients with chronic insomnia

Study on the efficacy and safety of Life Enhancer compound probiotics in the treatment of patients with chronic insomnia

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400087827
Enrollment
Unknown
Registered
2024-08-05
Start date
2024-08-10
Completion date
Unknown
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic insomnia

Interventions

Intervention group:On the basis of the original medication, Life Enhancer probiotic capsules were given one capsule each time, twice a day for 3 months.
Control group:On the basis of the original medication, one placebo capsule was given twice a day for 3 months.

Sponsors

Shanghai Fourth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) 45-70 years old 2) It meets the diagnostic criteria of chronic insomnia in the International Classification of Sleep Disorders, Third Edition (ICSD-3, 2014) 3) Voluntary subjects, able to read, understand and sign the informed consent form, cooperate with drug taking, follow up regularly and take samples.1) 45-70 years old 2) It meets the diagnostic criteria of chronic insomnia in the International Classification of Sleep Disorders, Third Edition (ICSD-3, 2014); 3) Voluntary subjects, able to read, understand and sign the informed consent form, cooperate with drug taking, follow up regularly and take samples.

Exclusion criteria

Exclusion criteria: 1. Known or suspected allergic or allergic constitution to the test drug; 2. Secondary insomnia caused by chronic pain, prostatic hyperplasia and other diseases; 3. The working and living environment can't guarantee suitable sleeping opportunities and sleeping environment (at least 8 hours before going to bed); 4. Serious physical illness or being in the acute stage of any disease; 5. It is known that you have dementia or mental illness and cannot cooperate; 6. Supplement probiotics related preparations and receive antibiotic treatment within 2 weeks before joining the group, including but not limited to other probiotic supplements, yogurt and other products; 7. There are cognitive and emotional drug adjustments within one month; 8. Have a history of drug abuse, or have a history of alcohol abuse in the past 6 months, or have other circumstances that reduce the possibility of joining the group or complicate the group according to the judgment of the researcher (alcohol abuse is defined as drinking more than 14 alcohol units per week, and one alcohol unit is a bottle of 350ml beer, 120ml wine or 30ml spirits with 40% alcohol content); 9. Have participated in any clinical research of other medical devices or drugs in the past 3 months; 10. Planned pregnancy during pregnancy, breastfeeding or research.

Design outcomes

Primary

MeasureTime frame
Score of Pittsburgh Sleep Quality Index Scale (PSQI);Score of Athens Insomnia Scale(AIS);Score of Insomnia Severity Index (ISI);

Secondary

MeasureTime frame
Score of Mini-mental State Examination(MMSE);Score of Montreal Cognitive Assessment(MoCA);Score of Hamilton Anxiety Scale(HAMA);Score of Hamilton Depression Scale(HAMD);Routine blood test;Liver and kidney function;Blood sugar;Blood lipid;Routine stool test;Inflammation index (CRP, cytokines);Serum cortisol;Serum adrenocorticotropic hormone;Fecal flora;

Countries

China

Contacts

Public ContactTao W

Shanghai Fourth People's Hospital

twu163@163.com+86 133 9123 2009

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026